AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20682548
Drug: Prolonged gemcitabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged gemcitabine and paclitaxel chemotherapy (arm B)
Trial: 19330493
Drug: Fixed-dose manidipine/delapril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose manidipine/delapril
Trial: 17570342
Drug: Single session
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single session of behavioral treatment involving self-exposure instructions
Trial: 15297125
Drug: Topical nonsteroid
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nonsteroid anti-inflammatory drugs
Trial: 15297125
Drug: Acupuncture, extracorporeal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture, extracorporeal shock wave therapy, manipulation, orthoses, low-energy laser, glycosaminoglycan polysulfate injection, botulinum toxin injection, topical nitric oxide application
Trial: 8838609
Drug: Fenfluramine (20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine (20, 40 mg)
Trial: 891280
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of fenoterol hydrobromide
Trial: 891280
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg of fenoterol hydrobromide
Trial: 891280
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of fenoterol hydrobromide
Trial: 891280
Drug: 24 mg
RxNorm normalized name: uracil 224 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 mg of ephedrine
Trial: 24065259
Drug: Contrast-enhanced sonography
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast-enhanced sonography with intravenous administration of 2.4 mL of sulfur hexafluoride
Trial: 21332811
Drug: Anti-cellulite cream
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-cellulite cream
Trial: 15220015
Drug: Amlodipine camsylate
RxNorm normalized name: amlodipine camsylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine camsylate (newly developed formulation)
Trial: 15220015
Drug: Amlodipine besylate
RxNorm normalized name: Amlodipine Besylate
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate (conventional formulation)
Trial: 19463517
Drug: Ezetimibe 5
RxNorm normalized name: EZETIMIBE 5MG/ROSUVASTATIN 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 5 mg
Trial: 11558859
Drug: Ezetimibe 5
RxNorm normalized name: EZETIMIBE 5MG/ROSUVASTATIN 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 5 mg and 10 mg
Trial: 11558859
Drug: Ezetimibe (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (all doses)
Trial: 9604858
Drug: Untreated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Untreated coffee (150 ml)
Trial: 9604858
Drug: Specially treated
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Specially treated coffee (150 ml)
Trial: 29667557
Drug: M2000 (β-D-mannuronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M2000 (β-D-mannuronic Acid) 500 mg orally twice daily for 12 weeks
Trial: 28513786
Drug: Atraumatic Restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atraumatic Restorative Treatment (ART) sealants
Trial: 25646254
Drug: Daily 4%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 4% chlorhexidine umbilical cord wash
Trial: 23617089
Drug: Clindamycin phosphate
RxNorm normalized name: Clindamycin Phosphate
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clindamycin phosphate (CP) 1.2%‐benzoyl peroxide (BPO) 2.5% gel
Trial: 9365092
Drug: Intramuscular methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular methylprednisolone
Trial: 9365092
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (oral prednisolone and intramuscular methylprednisolone)
Trial: 9365092
Drug: Corticosteroid tapering
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Corticosteroid tapering
Trial: 1471663
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (6 gm intravenous bolus)
Trial: 4059295
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g triletide
Trial: 4059296
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g triletide
Trial: 4059295
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g triletide
Trial: 31096724
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (SOC) treatment
Trial: 24946635
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (tamsulosin hydrochloride 0.2 mg once daily, indometacin 75 mg once daily)
Trial: 22325459
Drug: Finasteride (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride (1 mg/d)
Trial: 20849659
Drug: Multispecies probiotic
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multispecies probiotic intervention consisting of Lactobacillus rhamnosus GG, L. rhamnosus Lc705, Propionibacterium freudenreichii ssp. shermanii JS and Bifidobacterium breve Bb99
Trial: 7653442
Drug: Nicorandil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil (10 mg oral administration)
Trial: 2572631
Drug: Glycol-poly-siloxane gel
RxNorm normalized name: glycolate Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycol-poly-siloxane gel
Trial: 2572631
Drug: Weekly MRSA
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly MRSA colonization rate in neonates
Trial: 31307434
Drug: CHIP lifestyle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHIP lifestyle intervention programme (12 weeks) followed by 9 months of monthly follow-up appointments
Trial: 9308510
Drug: Metaproterenol sulfate
RxNorm normalized name: Metaproterenol Sulfate
DrugBank: Orciprenaline (DB00816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metaproterenol sulfate (1.3 mg, 2 inhalations every 4 hours while awake for 1 week)
Trial: 3732093
Drug: Chlorthalidone (25‐50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (25‐50 mg daily)
Trial: 26716656
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of encapsulated Cassia cinnamon bark (CASS)
Trial: 26716656
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of encapsulated placebo (PLC)
Trial: 22735863
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (5 g/day for six months)
Trial: 22735863
Drug: Placebo (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5 g/day of maltodextrin for six months)
Trial: 19262361
Drug: Optimal standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal standard heart failure therapy
Trial: 9231199
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of DEC
Trial: 8330600
Drug: subarachnoid bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: subarachnoid bupivacaine plus epidural morphine and bupivacaine
Trial: 8330600
Drug: subarachnoid bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: subarachnoid bupivacaine plus intravenous midazolam and buprenorphine
Trial: 8330600
Drug: epidural bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: epidural bupivacaine plus epidural morphine
Trial: 3033040
Drug: Local antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local antimicrobial prophylaxis (50 mg of polymyxin B, 80 mg of gentamicin, 300 mg of amphotericin B)
Trial: 25986159
Drug: Formulated honey
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulated honey (53.5 g daily for 40 days)
Trial: 25509258
Drug: Compound Qizhu
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Qizhu Granule (CQG) plus Lamivudin (LAM) and Adefovir (ADV)
Trial: 16178481
Drug: 2% mupirocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% mupirocin cream applied daily to the exit site
Trial: 8853261
Drug: Pancrease HL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancrease HL (25,000 units of lipase per capsule, 3 capsules/day)
Trial: 8853261
Drug: Creon (8000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creon (8000 units of lipase per capsule, 9 capsules/day)
Trial: 8853261
Drug: Pancrease HL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancrease HL with omeprazole (20 mg/day)
Trial: 8853261
Drug: Creon with
RxNorm normalized name: Creon
DrugBank: Pancrelipase lipase (DB13147)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creon with omeprazole (20 mg/day)
Trial: 1737543
Drug: Insulin dose
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin dose minimization
Trial: 30920584
Drug: Intra-procedural only
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intra-procedural only bivalirudin infusion
Trial: 27283364
Drug: Saccharomyces boulardii
RxNorm normalized name: Saccharomyces boulardii
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saccharomyces boulardii (SB) 500 mg/day for 5 days
Trial: 18835953
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (n = 19,326)
Trial: 17786067
Drug: Nebivolol 1.25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol 1.25, 2.5, 5, 10, 20, or 40 mg once daily for up to 84 days
Trial: 14638340
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy regimen including amoxicillin and clarithromycin with omeprazole, lansoprazole, or rabeprazole
Trial: 10826574
Drug: Transcervical intrauterine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcervical intrauterine instillation of 5 mL of 2% lignocaine
Trial: 8865110
Drug: Dipeptide-containing solution
RxNorm normalized name: palmitoyl dipeptide-7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipeptide-containing solution (glycyl-glutamine/glycyl-tyrosine) infused at 0.60 mL/h/kg; 82.2 mg total dipeptides/amino acids/h/kg
Trial: 8865110
Drug: Conventional amino
RxNorm normalized name: silk amino acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional amino acid solutions infused at 0.73 mL/h/kg; 83.2 mg total amino acids/h/kg
Trial: 2272187
Drug: Controlled-release indomethacin
RxNorm normalized name: indomethacin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release indomethacin (75 mg)
Trial: 19430350
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of losartan and nebivolol
Trial: 16963731
Drug: Gefitinib (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib (250 or 500 mg/d)
Trial: 16831672
Drug: Steroid (71
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid (71 patients)
Trial: 30259769
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of 1% lidocaine
Trial: 30259769
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of 2% lidocaine
Trial: 8840367
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blockers, digoxin, and beta-blockers (specific dosages and duration not provided)
Trial: 6133056
Drug: Single-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose therapy with chloroquine (10 mg base/kg)
Trial: 6133056
Drug: Standard therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapeutic regimen of chloroquine (25 mg base/kg)
Trial: 22609423
Drug: Pomegranate juice
RxNorm normalized name: pomegranate juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pomegranate juice (100 cc, three times a week for 1 year)
Trial: 18172906
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg/day)
Trial: 12211219
Drug: Celecoxib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (200 mg) with aspirin (325 mg)
Trial: 12211219
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with aspirin (325 mg)
Trial: 8720887
Drug: Propofol 2
RxNorm normalized name: propofol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2 mg/kg for induction, 5-6 mg/kg.h for maintenance
Trial: 1917320
Drug: Topical isosorbide-mononitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical isosorbide-mononitrate (ISMO) 0.5% eye drops
Trial: 1917320
Drug: Topical isosorbide-mononitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical isosorbide-mononitrate (ISMO) 2% eye drops
Trial: 31892336
Drug: Aromatase inhibitor
RxNorm normalized name: Aromatase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aromatase inhibitor (AI) therapy for 2 weeks
Trial: 31892336
Drug: No presurgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No presurgical treatment (control)
Trial: 29319719
Drug: Low-cost negative-pressure
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-cost negative-pressure wound therapy (USP)
Trial: 29319719
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available therapy device (VAC)
Trial: 23612436
Drug: Methylphenidate (Ritalin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (Ritalin, 20 mg)
Trial: 17053854
Drug: Peer norms
RxNorm normalized name: Worm Protector 2X
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer norms supporting safe injection
Trial: 9883955
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy programme
Trial: 9100427
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) at doses of 5 mg, 10 mg, 15 mg, and 20 mg
Trial: 2492893
Drug: Etidronate disodium
RxNorm normalized name: Etidronate Disodium
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etidronate disodium 400 mg daily for 3 months
Trial: 2492893
Drug: Etidronate disodium
RxNorm normalized name: Etidronate Disodium
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etidronate disodium (after stopping therapy)
Trial: 4851464
Drug: Intranasal DDAVP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal DDAVP (twice-daily)
Trial: 4851464
Drug: Intramuscular DDAVP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular DDAVP (single daily injections)
Trial: 25254570
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment control (just self-massage)
Trial: 23341486
Drug: Strontium ranelate
RxNorm normalized name: Strontium ranelate
DrugBank: Strontium ranelate (DB09267)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Strontium ranelate at 2 g/d (n = 174)
Trial: 18289898
Drug: Brinzolamide suspension,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brinzolamide suspension, 1%, dosed twice daily
Trial: 18289898
Drug: Levobetaxolol suspension,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobetaxolol suspension, 0.5%, dosed twice daily
Trial: 1394814
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy consisting of monthly instillations of mitomycin C and doxorubicin for 12 months
Trial: 1394814
Drug: Intravesical combination
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical combination chemotherapy (mitomycin C and doxorubicin)
Trial: 27126154
Drug: Oral nutrition
RxNorm normalized name: BAGS/TUBES/SUPPLIES FOR ORAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutrition supplements (ONS)
Trial: 24953578
Drug: Oral zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zinc sulfate (10 mg/d)
Trial: 20977764
Drug: Extracorporeal focused
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal focused shock wave therapy (2000 impulses, 0.25 mJ/m2 every 1-2 weeks) plus specific gluteal strength exercise training
Trial: 20977764
Drug: Sham extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham extracorporeal focused shock wave therapy (2000 impulses, 0.01 mJ/m2 every 1-2 weeks) plus specific gluteal strength exercise training
Trial: 18927173
Drug: Aspirin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (100 mg daily) plus antioxidant capsule
Trial: 18927173
Drug: Aspirin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (100 mg daily) plus placebo capsule
Trial: 18927173
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet plus antioxidant capsule
Trial: 18927173
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet plus placebo capsule
Trial: 9708873
Drug: Dietary intake
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary intake of fresh fruit (g/day)
Trial: 9708873
Drug: Dietary vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary vitamin C intake (mg/day) measured by DR
Trial: 9708873
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of vitamin C supplements
Trial: 7635771
Drug: Overall Treatment
RxNorm normalized name: Healthy Kids Overall Health Gummies Soft Chew
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall Treatment Time (OTT)
Trial: 2359302
Drug: Couples group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Couples group therapy condition
Trial: 2359302
Drug: Standard individual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard individual therapy condition
Trial: 30131583
Drug: Corticosteroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid treatment (exact dosage not specified)
Trial: 26787505
Drug: Tocilizumab (TCZ)
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab (TCZ) 4 mg/kg
Trial: 22039165
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of biomarkers
Trial: 12583554
Drug: Amoxicillin‐clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin‐clavulanic acid (2.2 g)
Trial: 15724911
Drug: Incidental encoding
RxNorm normalized name: Autologous CD34+ cells encoding βA-T87Q-Globin gene
DrugBank: Betibeglogene autotemcel (DB16900)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incidental encoding of temporal context; no specific dosage or duration mentioned.
Trial: 15724911
Drug: Intentional encoding
RxNorm normalized name: pork intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intentional encoding of temporal context; no specific dosage or duration mentioned.
Trial: 15724911
Drug: Retrieval of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrieval of encoding context as a cue for list occurrence; no specific dosage or duration mentioned.
Trial: 15724911
Drug: Evaluating temporal
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evaluating temporal distance from the strength of the memory trace; no specific dosage or duration mentioned.
Trial: 10402402
Drug: In-house Earle's
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-house Earle's balanced salt solution (EBSS)
Trial: 10402402
Drug: Commercially prepared
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercially prepared Earle's balanced salt solution (EBSS)
Trial: 7720336
Drug: L-arginine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (0.1 g/kg)
Trial: 7720336
Drug: L-arginine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (0.2 g/kg)
Trial: 2035794
Drug: Subcutaneous wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous wound infiltration with 20 ml of 0.5% bupivacaine
Trial: 7034564
Drug: Quinine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine plus a single dose of pyrimethamine‐sulfadoxine (Fansidar)